FAQ: Izotropic Corporation's BreastCT.com Educational Platform and Market Awareness Strategy

What is BreastCT.com and who launched it?

BreastCT.com is a comprehensive educational resource focused on dedicated breast CT technology and IzoView’s clinical advantages, launched by Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF).

Why did Izotropic create BreastCT.com?

Izotropic created BreastCT.com to address the fundamental commercialization challenge of market education for breakthrough medical technologies, requiring comprehensive stakeholder education across patients, clinicians, and healthcare administrators.

What specific technology does BreastCT.com focus on educating about?

The platform focuses on educating about dedicated breast CT technology and IzoView’s clinical advantages, particularly for dense breast tissue imaging.

How is the BreastCT.com platform designed to evolve over time?

The platform is designed to evolve alongside company progression through clinical studies, regulatory phases, and commercial launch milestones.

Who are the target audiences for this educational platform?

The platform targets patients, clinicians, and healthcare administrators who need education about breakthrough breast imaging technology.

What challenge does BreastCT.com help address for medical device companies?

It addresses the market education challenge that medical device companies face when developing breakthrough technologies that represent genuine advances over existing standards of care.

Where can investors find the latest news and updates about Izotropic Corporation?

Investors can find the latest news and updates in the company’s newsroom at ibn.fm/IZOZF.

What is the strategic positioning context mentioned for IzoView’s commercial potential?

The strategic positioning is within the context of successful imaging category creation, which provides a clear market reference framework for IzoView’s commercial potential.